Copied
 
 
Formål
HistorikStartStop
Selskabets formål er at drive forskning, produktudvikling, marketing, handel, service27.05.201417.03.2022
Virksomheden har ikke ændret Formål i sin levetid.
Ingen nuværende registrering.
Status
HistorikStartStop
OPLØST EFTER FRIVILLIG LIKVIDATION17.03.202217.03.2022
UNDER FRIVILLIG LIKVIDATION27.04.202116.03.2022
NORMAL17.06.200426.04.2021
Ingen nuværende registrering.
Branche
HistorikStartStop
Engroshandel med medicinalvarer og sygeplejeartikler (464610)01.01.201217.03.2022
Fremstilling af farmaceutiske præparater (212000)01.01.200931.12.2011
Anden teknisk rådgivning (711290)01.01.200831.12.2008
Anden teknisk rådgivning (742090)17.06.200431.12.2007
Ingen nuværende registrering.
Revision
HistorikStartStop
false17.06.200417.03.2022
Virksomheden har ikke ændret Revision i sin levetid.
Ingen nuværende registrering.
Revisor
HistorikStartStop
CHRISTENSEN KJÆRULFF STATSAUTORISERET REVISIONSAKTIESELSKAB14.12.201517.03.2022
EY Godkendt Revisionspartnerselskab10.10.201414.12.2015
ERNST & YOUNG DENMARK P/S11.07.201110.10.2014
ERNST & YOUNG DENMARK P/S17.06.200411.07.2011
Ingen nuværende registrering.
Form
HistorikStartStop
8014.05.202017.03.2022
6017.06.200413.05.2020
Ingen nuværende registrering.
Kontakt
HistorikStartStop
dchristensen@opgen.com08.01.201817.03.2022
the@advandx.com26.02.201407.01.2018
thais.johansen@advandx.com16.10.200625.02.2014
Ingen nuværende registrering.
Telefon
HistorikStartStop
2618781308.01.201817.03.2022
4516079910.12.200407.01.2018
Ingen nuværende registrering.
Navne
Ingen nuværende registrering.
Tegningsregel
HistorikStartStop
Virksomheden tegnes af en likvidator27.04.202117.03.2022
Selskabet tegnes af 2 bestyrelsesmedlemmer eller af et bestyrelsesmedlem og en direktør18.05.202026.04.2021
Selskabet tegnes af 2 bestyrelsesmedlemmer, et bestyrelsesmedlem og en direktør eller den samlede bestyrelse27.05.201417.05.2020
Ingen nuværende registrering.
Ansatte
19.05.2024
Kapital
19.05.2024
Fra årsrapport
Type af revisorbistand:Revisionspåtegning
Virksomhedens regnskabsklasse:Regnskabsklasse B
Grundlag for konklusion (revision):Basis for opinion We conducted our audit in accordance with international standards on auditing and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the section “Auditor’s responsibilities for the audit of the financial statements”. We are independent of the company in accordance with international ethical requirements for auditors (IESBA’s Code of Ethics), and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Konklusion (revision):We have audited the financial statements of OpGen ApS for the financial year 1 January - 31 December 2020, which comprise income statement, statement of financial position, statement of changes in equity, notes and accounting policies. The financial statements have been prepared in accordance with the Danish Financial Statements Act. In our opinion, the financial statements present a fair view of the company's assets, equity and liabilities, and financial position at 31 December 2020 and of the results of the company's activities for the financial year 1 January - 31 December 2020 in accordance with the Danish Financial Statements Act.
Udtalelse om ledelsesberetningen (revision):Statement on the management commentary Management is responsible for the management commentary. Our opinion on the financial statements døs not cover the management commentary, and we express no assurance opinion thereon. In connection with our audit of the financial statements, it is our responsibility to read the management commentary and to consider whether the management commentary is materially inconsistent with the financial statements or the evidence obtained during the audit, or whether it otherwise appears to contain material misstatement. Furthermore, it is our responsibility to consider whether the management commentary provides the information required under the Danish Financial Statements Act. Based on the work we have performed, we believe that management commentary is consistent with the financial statements and that it has been prepared in accordance with the provisions of the Danish Financial Statement Act. We did not discover any material misstatement in the management commentary.
Bibranche
Ingen nuværende registrering.
Ingen historik.
Børsnoteret
19.05.2024
Ingen nuværende registrering.
Ingen historik.
Hjemmeside
19.05.2024
Ingen nuværende registrering.
Ingen historik.
Vi bruger cookies til at øge oplevelsen og målrette vores markedsføring.
Ved at klikke OK tillader du brug af cookies. Læs mere her.
OK